Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations
Open accessThe DOI matches its Crossref record; 523 of the 528 references it cites were found in a registry or an index, and 5 are not checked yet.
Abstract
Long-term survival rates after a diagnosis of breast cancer are steadily rising. This is good news, but clinicians must also recognize that this brings new challenges to the medical community. As breast cancer becomes a chronic condition rather than a life-threatening illness owing to advances in early diagnosis and more effective treatments, health care practitioners must recognize and manage the long-term sequelae of the constellation of therapeutic modalities. Survivors of breast cancer represent a unique and extremely complex group of patients; not only do they have the challenge of dealing with multiple long-term side effects of treatment protocols, but many are also forced to address the preexisting comorbidities of their therapies, which often include multiple other issues. Therapies have additional and/or additive side effects that may interfere with treatments directed toward the new primary diagnosis of breast cancer. Our mandate is to establish a smooth transition from patient with breast cancer to survivor of breast cancer while providing ongoing and future guidance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–528 of 528
The effects of aromatase inhibitors on lipids and thrombosis
Bundred, N. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602692 · Cited by 86
Mastro, L. D., Perrone, F., Repetto, L., Manzione, L., Zagonel, V., Fratino, L., Marenco, D., Venturini, M., Maggi, E., Bighin, C., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi056 · Cited by 86
Evaluation of dose to cardiac structures during breast irradiation
Aznar, M. C., Korreman, S. S., Pedersen, A., Persson, G. F., Josipović, M., & Specht, L. (2011) · British Journal of Radiology · doi:10.1259/bjr/12497075 · Cited by 86
Relationship between Subclinical Thyroid Dysfunction and Femoral Neck Bone Mineral Density in Women
Lee, W., Oh, K. W., Rhee, E., Jung, C., Kim, S. W., Yun, E. J., Tae, H. J., Baek, K. H., Kang, M. I., Choi, M. G., et al. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.09.009 · Cited by 86
Medication Adherence is a Partnership, Medication Compliance is Not
Gould, E., & Mitty, E. (2010) · Geriatric Nursing · doi:10.1016/j.gerinurse.2010.05.004 · Cited by 84
Breast Cancer and Sexuality: Multi-modal Treatment Options (CME)
Krychman, M., & Katz, A. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02566.x · Cited by 83
Cardiac changes with cyclophosphamide
Steinherz, L. J., Steinherz, P. G., Mangiacasale, D., O’Reilly, R. J., Allen, J. C., Sorell, M., & Miller, D. R. (1981) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950090502 · Cited by 83
ACOG Committee Opinion No. 336: Tamoxifen and Uterine Cancer
(2006) · Obstetrics and Gynecology · doi:10.1097/00006250-200606000-00057 · Cited by 83
Rosedale, M., & Fu, M. R. (2010) · Oncology Nursing Forum · doi:10.1188/10.onf.e28-e33 · Cited by 82
Ziller, V., Kyvernitakis, I., Knöll, D., Storch, A., Hars, O., & Hadji, P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-407 · Cited by 82
New Insights Into Cancer-Associated Thrombosis
Sousou, T., & Khorana, A. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.182196 · Cited by 82
Prospective Surveillance for Perioperative Venous Thrombosis
Flinn, W. R. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430170018002 · Cited by 79
Recurrences and second primary breast cancers in older women with initial early‐stage disease
Geiger, A. M., Thwin, S. S., Lash, T. L., Buist, D. S. M., Prout, M. N., Wei, F., Field, T. S., Ulcickas Yood, M., Frost, F. J., Enger, S. M., et al. (2007) · Cancer · doi:10.1002/cncr.22472 · Cited by 79
Osteoporosis: An Under-appreciated Complication of Diabetes
Brown, S. A., & Sharpless, J. L. (2004) · Clinical Diabetes · doi:10.2337/diaclin.22.1.10 · Cited by 78
Metabolic and Clinical Consequences of Hyperthyroidism on Bone Density
Gorka, J., Taylor-Gjevre, R. M., & Arnason, T. (2013) · International Journal of Endocrinology · doi:10.1155/2013/638727 · Cited by 78
PREVALENCE AND AETIOLOGY OF LYMPHOEDEMA AFTER BREAST CANCER TREATMENT IN SOUTHERN TASMANIA
Edwards, T. L. (2000) · Australian and New Zealand Journal of Surgery · doi:10.1046/j.1440-1622.2000.01839.x · Cited by 77
Heilman, K., Zilmer, M., Zilmer, K., & Tillmann, V. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0076-4 · Cited by 77
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9124-7 · Cited by 77
Lifestyle medicine: treating the causes of disease.
Hyman, M. A., Ornish, D. M., & Roizen, M. F. (2009) · PubMed · Cited by 76
Cancer risk in women with previous breast cancer
Levi, F., Te, V.-C., Randimbison, L., & Vecchia, C. L. (2002) · Annals of Oncology · doi:10.1093/annonc/mdg028 · Cited by 76
Risk of second primary malignancies in patients with cutaneous melanoma
Schmid-Wendtner, M.-H., Baumert, J. J., Wendtner, C.-M., Plewig, G., & Volkenandt, M. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04507.x · Cited by 76
Kanis, J. А., & McCloskey, E. V. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00090-5 · Cited by 75
A Shortage of Oncologists? The American Society of Clinical Oncology Workforce Study
Hortobagyi, G. N. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9397 · Cited by 75
Primary Malignancy after Primary Female Breast Cancer in the South of the Netherlands, 1972–2001
Soerjomataram, I., Louwman, M. W. J., de Vries, E., Lemmens, V. E. P. P., Klokman, W. J., & Coebergh, J. W. W. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-4016-2 · Cited by 74
Melanoma in the chinese of Hong Kong. Emphasis on volar and subungual sites
Collins, R. J. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7<1482::aid-cncr2820540745>3.0.co;2-o · Cited by 73
Depression in women with metastatic breast cancer: A review of the literature
Caplette-Gingras, A., & Savard, J. (2008) · Palliative and Supportive Care · doi:10.1017/s1478951508000606 · Cited by 73
Increased fracture rate in women with breast cancer: a review of the hidden risk
Body, J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-384 · Cited by 72
Untch, M., Muscholl, M. W., Tjulandin, S., Jonat, W., Meerpohl, H. G., Lichinitser, M., Manikhas, A., Coumbos, A., Kreienberg, R., du Bois, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9709 · Cited by 72
Breast cancer survivors in the United States
Angelis, R. D., Tavilla, A., Verdecchia, A., Scoppa, S., Hachey, M., Feuer, E. J., & Mariotto, A. B. (2009) · Cancer · doi:10.1002/cncr.24217 · Cited by 71
Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism
Rickles, F. R., & Levine, M. N. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022404 · Cited by 71
Antithrombotic Strategies in Patients with Cancer
Prandoni, P. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657517 · Cited by 71
Westley, R., & May, F. E. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/632461 · Cited by 70
Dual HER2-targeted approaches in HER2-positive breast cancer
Ahn, E. R., & Vogel, C. L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1781-y · Cited by 68
Panet-Raymond, V., Truong, P. T., McDonald, R. E., Alexander, C., Ross, L. A., Ryhorchuk, A., & Watson, P. H. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.063 · Cited by 67
Lumachi, F., Camozzi, V., Tombolan, V., & Luisetto, G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04955.x · Cited by 65
Giordano, S. H., Booser, D. J., Murray, J. L., Ibrahim, N. K., Rahman, Z. U., Valero, V., Theriault, R. L., Rosales, M., Rivera, E., Frye, D. K., et al. (2002) · PubMed · Cited by 65
A prospective study of breast lymphedema: frequency, symptoms, and quality of life
Degnim, A. C., Miller, J. P., Hoskin, T. L., Boughey, J. C., Loprinzi, M., Thomsen, K. M., Maloney, S. D., Baddour, L. M., & Cheville, A. L. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2004-x · Cited by 64
Second primary tumors in patients with cutaneous malignant melanoma
Bhatia, S., Estrada-Batres, L., Odom‐Maryon, T., Bogue, M. K., & Chu, D. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991115)86:10<2014::aid-cncr19>3.0.co;2-4 · Cited by 63
Bone disease in thyrotoxicosis.
Reddy, P., Harinarayan, C. V., Sachan, A., Suresh, V., & Rajagopal, G. M. (2012) · PubMed Central · Cited by 62
Cancer, Coagulation, and Anticoagulation
Letai, A., & Kuter, D. J. (1999) · The Oncologist · doi:10.1634/theoncologist.4-6-443 · Cited by 62
DEGRO Practical Guidelines for Radiotherapy of Breast Cancer II
Sautter‐Bihl, M., Souchon, R., Budach, W., Sedlmayer, F., Feyer, P., Harms, W., Haase, W., Dunst, J., Wenz, F. K., & Sauer, R. (2008) · Strahlentherapie und Onkologie · doi:10.1007/s00066-008-1901-8 · Cited by 61
30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.
Armer, J. M., Stewart, B. R., & Shook, R. P. (2009) · PubMed · Cited by 61
Youssef, G. S., & Links, M. J. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505040-00003 · Cited by 61
Perre, C. I., Hoefnagel, C. A., Kroon, B. B. R., Zoetmulder, F. A. N., & Rutgers, E. J. T. (1996) · British journal of surgery · doi:10.1046/j.1365-2168.1996.02349.x · Cited by 61
Heart of Darkness: The Downside of Trastuzumab
Hayes, D. F., & Picard, M. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5143 · Cited by 61
Mastectomies on the Rise for Breast Cancer: “The Tide Is Changing”
Balch, C. M., & Jacobs, L. K. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0634-y · Cited by 60
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study
Coleman, R. E., Banks, L. M., Girgis, S. I., Vrdoljak, E., Fox, J. N., Cawthorn, S., Patel, A., Bliss, J. M., Coombes, R. C., & Kilburn, L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1121-7 · Cited by 59
From Policy To Patients And Back: Surgical Treatment Decision Making For Patients With Breast Cancer
Katz, S. J., & Hawley, S. T. (2007) · Health Affairs · doi:10.1377/hlthaff.26.3.761 · Cited by 59
Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer.
Cummings, F. J., Gray, R., Davis, T. E., Tormey, D. C., Harris, J. E., Falkson, G., & Arseneau, J. C. (1986) · PubMed · Cited by 57
Long‐term safety of filgrastim (rhG‐CSF) administration
Confer, D. L., & Miller, J. P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06524.x · Cited by 57
Petrelli, F., Coinu, A., Cabiddu, M., Ghilardi, M., Lonati, V., & Barni, S. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2629-4 · Cited by 57
Role of proliferation in HER2 status predicted response to doxorubicin
Campiglio, M., Somenzi, G., Olgiati, C., Beretta, G. L., Balsari, A., Zaffaroni, N., Valagussa, P., & Ménard, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11113 · Cited by 57
Ackland, S. P., Antón, A., Breitbach, G. P., Colajori, E., Tursi, J. M., Delfino, C., Efremidis, A. P., Ezzat, A. A., Fittipaldo, A., Kolarić, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.943 · Cited by 56
Lymph Node Status and Breast Cancer-related Lymphedema
Purushotham, A. D., Britton, T. M. B., Klevesath, M., Chou, P., Agbaje, O. F., & Duffy, S. W. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000259390.51203.7b · Cited by 56
Gynaecological monitoring during tamoxifen therapy
Bissett, D., Davis, J., & George, W. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90747-1 · Cited by 56
Risk Factors Associated with Breast Lymphedema
Boughey, J. C., Hoskin, T. L., Cheville, A. L., Miller, J. P., Loprinzi, M., Thomsen, K. M., Maloney, S. D., Baddour, L. M., & Degnim, A. C. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3408-5 · Cited by 55
Vogelvang, T. E., van der Mooren, M. J., Mijatovic, V., & Kenemans, P. (2006) · Drugs · doi:10.2165/00003495-200666020-00005 · Cited by 55
Bartsch, R., Wenzel, C., Hussian, D., Pluschnig, U., Sevelda, U., Koestler, W. J., Altorjai, G., Locker, G. J., Mader, R. M., Zielinski, C. C., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-63 · Cited by 54
Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer
Liu, Y., Pérez, M., Aft, R., Massman, K., Robinson, E. D., Myles, S., Schootman, M., Gillanders, W. E., & Jeffe, D. B. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1051 · Cited by 54
Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.02.009 · Cited by 53
Evidence that Tamoxifen Preserves Bone Density in Late Postmenopausal Women with Breast Cancer
Resch, A., Biber, E., Seifert, M., & Resch, H. (1998) · Acta Oncologica · doi:10.1080/028418698430007 · Cited by 53
Quantitative DNA Fingerprinting May Distinguish New Primary Breast Cancer From Disease Recurrence
Schlechter, B. L., Yang, Q., Larson, P. S., Golubeva, A., Blanchard, R. A., Morenas, A. D. L., & Rosenberg, C. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.123 · Cited by 53
Schonfeld, S. J., Curtis, R. E., Anderson, W. F., & de González, A. B. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0054-3 · Cited by 51
Depression care for people with cancer: a collaborative care intervention
Walker, J., & Sharpe, M. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.05.010 · Cited by 51
Font, C., Carmona‐Bayonas, A., Fernández-Martínez, A., Beato, C., Vargas, A., Gascón, P., & Otero, R. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0038 · Cited by 51
Lymphedema development following breast cancer surgery with full axillary resection.
Veen, P. V. D., Voogdt, N. D., Lievens, P., Duquet, W., Lamote, J., & Sacre, R. J. (2004) · PubMed · Cited by 49
Applying the Precautionary Principle to Nutrition and Cancer
Gonzales, J. F., Barnard, N. D., Jenkins, D. J. A., Lanou, A. J., Davis, B. C., Saxe, G. A., & Levin, S. (2014) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.866527 · Cited by 48
Deep venous thrombosis after myocardial infarction. Predisposing factors.
Simmons, A. V., Sheppard, M., & Cox, A. (1973) · Heart · doi:10.1136/hrt.35.6.623 · Cited by 48
Lenihan, D. J., & Esteva, F. J. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0112 · Cited by 47
The evolution of the conservative approach to breast cancer
Luini, A., Gatti, G. M., Zurrida, S., Talakhadze, N., Brenelli, F. P., Gilardi, D., Paganelli, G., Orecchia, R., Cassano, E., Viale, G., et al. (2007) · The Breast · doi:10.1016/j.breast.2006.11.001 · Cited by 45
Venous thromboembolism and cancer
Rahr, H. B., & Sørensen, J. V. (1992) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199203040-00012 · Cited by 44
Is mastectomy overused? A call for an expanded research agenda.
Lantz, P., Zemencuk, J. K., & Katz, S. (2002) · Health Services Research · doi:10.1111/1475-6773.030 · Cited by 44
Castel, L. D., Hartmann, K. E., Mayer, I. A., Saville, B. R., Alvarez, J., Boomershine, C. S., Abramson, V. G., Chakravarthy, A. B., Friedman, D. L., & Cella, D. F. (2013) · Cancer · doi:10.1002/cncr.28016 · Cited by 43
Graham, P. (2002) · The Breast · doi:10.1054/brst.2001.0370 · Cited by 43
Monnerat, C., Chompret, A., Kannengiesser, C., Avril, M., Janin, N., Spatz, A., Guinebretière, J., Marian, C., Barrois, M., Boitier, F., et al. (2007) · Familial Cancer · doi:10.1007/s10689-007-9143-y · Cited by 43
Life threatening interaction between tamoxifen and warfarin.
Lodwick, R., McConkey, B., & Brown, A. M. (1987) · BMJ · doi:10.1136/bmj.295.6606.1141-b · Cited by 43
Physical activity and breast cancer survival
Ogunleye, A. A., & Holmes, M. D. (2009) · Breast Cancer Research · doi:10.1186/bcr2351 · Cited by 42
Cancer Patients and Awareness of Venous Thromboembolism
Sousou, T., & Khorana, A. A. (2009) · Cancer Investigation · doi:10.3109/07357900902744544 · Cited by 42
Oral anticoagulants and the risk of osteoporotic fractures among elderly
Pilon, D., Castilloux, A., Dorais, M., & LeLorier, J. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.888 · Cited by 41
Lymphedema and breast cancer: a review of the literature
Michael, S., Stefanaki, C., & Kontzoglou, K. (2011) · Breast Cancer · doi:10.1007/s12282-010-0246-1 · Cited by 41
Lung cancer after treatment for breast cancer
Lorigan, P. C., Califano, R., Finn, C. F., Howell, A., & Thatcher, N. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70056-5 · Cited by 40
Susceptibility to Breast Cancer: Hereditary Syndromes and Low Penetrance Genes
Nusbaum, R., Vogel, K. J., & Ready, K. (2007) · Breast Disease · doi:10.3233/bd-2007-27103 · Cited by 38
Adherence with adjuvant hormonal therapy for breast cancer
Ruddy, K. J., & Partridge, A. H. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp039 · Cited by 38
Bone Loss in Thyroid Disease: Role of Low TSH and High Thyroid Hormone
Abe, E., Sun, L., Mechanick, J., Iqbal, J. Z., Yamoah, K., Baliram, R., Arabi, A., Moonga, B. S., Davies, T. F., & Zaidi, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.062 · Cited by 37
Prospective Study Evaluating Oncological Safety of Axillary Reverse Mapping
Schünemann, E., Dória, M. T., Silvestre, J. B. C. H., Gasperin, P., Cavalcanti, T. C. S., & Budel, V. M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3626-5 · Cited by 36
Risk Factors for Colorectal Cancer Following Breast Cancer
Kmet, L. M., Cook, L., Weiss, N., Schwartz, S., & White, E. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023926401227 · Cited by 35
Ferrandez, J.-C., Serin, D., & Bouges, S. (1996) · PubMed · Cited by 35
[Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo, M. (2001) · PubMed · Cited by 34
Heil, J., Buehler, A., Golatta, M., Rom, J., Schipp, A., Harcos, A., Schneeweiß, A., Rauch, G., Sohn, C., & Junkermann, H. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr064 · Cited by 34
Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy
Montemurro, F., & Aglietta, M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0033 · Cited by 33
Magné, N., Chargari, C., MacDermed, D. M., Conforti, R., Védrine, L., Spano, J., & Khayat, D. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.01.012 · Cited by 32
Risk factors for second primary tumours in breast cancer survivors
Sánchez, L., Lana, A., Hidalgo, A., Rodríguez, J. M., Valle, M. O. D., Cueto, A., Folgueras, M., Belyakova, E., Comendador, M. A., & López, M. L. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282f75ee5 · Cited by 32
Biological therapies in breast cancer: Common toxicities and management strategies
Barroso‐Sousa, R., Santana, I. A. D., Testa, L., Gagliato, D. D. M., & Mano, M. S. (2013) · The Breast · doi:10.1016/j.breast.2013.09.009 · Cited by 31
Journal of Clinical Oncology Update on Progress in Cancer Survivorship Care and Research
Ganz, P. A., Earle, C. C., & Goodwin, P. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3886 · Cited by 31
Beadle, G., Baade, P. D., & Fritschi, L. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn530 · Cited by 30
Cardiovascular Safety Profiles of Aromatase Inhibitors
Nabholtz, J., & Gligorov, J. (2006) · Drug Safety · doi:10.2165/00002018-200629090-00003 · Cited by 29
Intensive lifestyle changes and health reform
Ornish, D. M. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70175-5 · Cited by 29
Langer, S., Guenther, J., Haigh, P. I., & DiFronzo, L. A. (2004) · The American Surgeon · doi:10.1177/000313480407001011 · Cited by 28
Comparison and co-relation of invasive and noninvasive methods of ejection fraction measurement.
Godkar, D., Bachu, K., Dave, B., Megna, R., Niranjan, S., & Khanna, A. K. (2007) · PubMed · Cited by 28
Néstor Soto, I., Pruzzo, R., Eyzaguirre, F. C., Íñiguez, G., López, P. V., Mohr, J., Pérez‐Bravo, F., CASSORLA, F. G., & Ethel Codner, D. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.10.002 · Cited by 28
Yi, M., Cormier, J. N., Xing, Y., Giordano, S. H., Chai, C. Y.-H., Meric‐Bernstam, F., Vlastos, G., Kuerer, H. M., Mirza, N. Q., Buchholz, T. A., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2774-8 · Cited by 27
Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone.
López, P. J. T., Lopez, C., de Mora, F. N., Montes, J. A. R., Albero, J. S., Mañez, A. N., & Casas, A. G. (2011) · PubMed · Cited by 22
Predicting the Risk of Secondary Lung Malignancies Associated With Whole-Breast Radiation Therapy
Ng, J., Shuryak, I., Xu, Y., Chao, K., Brenner, D. J., & Burri, R. J. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.052 · Cited by 21
Which Breast Cancer Patients Should Really Worry About Radiation-Induced Heart Disease—And How Much?
Recht, A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.7909 · Cited by 21
Venous Thromboembolism Prevention in Cancer Outpatients
Khorana, A. A. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0164 · Cited by 21
SEGAL, R. J., Pond, G. R., Vallis, M., Dion, M.-J., Pritchard, K. I., Ligibel, J., Levine, M. N., & Goodwin, P. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.512 · Cited by 21
Adjuvant therapy in breast cancer and venous thromboembolism
Mandalà, M., & Tondini, C. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.280 · Cited by 20
Lamart, S., Stovall, M., Simon, S. L., Smith, S. A., Weathers, R. E., Howell, R. M., Curtis, R. E., Aleman, B. M. P., Travis, L. B., Kwon, D., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.03.014 · Cited by 20
Goodwin, P. J. (2013) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2013.10.044 · Cited by 20
Impact on Cardiac Toxicity With Trastuzumab and Radiotherapy: The Question Is Still Ongoing
Magné, N., Védrine, L., & Chargari, C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6918 · Cited by 18
Physician Update: Total Health
Tuso, P. J. (2014) · The Permanente Journal · doi:10.7812/tpp/13-120 · Cited by 17
Self-citationPrevention of Bone Loss After Withdrawal of Tamoxifen
Cohen, A., Fleischer, J. B., Johnson, M. K., Brown, I., Joe, A. K., Hershman, D. L., McMahon, D. J., & Silverberg, S. J. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.162 · Cited by 17
Cardiovascular Actions of Selective Estrogen Receptor Modulators and Phytoestrogens
Nandur, R., Kumar, K., & Villablanca, A. C. (2004) · Preventive Cardiology · doi:10.1111/j.1520-037x.2006.2527.x · Cited by 16
Age-specific analyses of breast cancer versus heart disease mortality in women.
Cantó, J., & Kiefe, C. (2014) · American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.055 · Cited by 16
Saag, K. G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1231 · Cited by 16
Matters of the heart: cardiovascular disease in U.S. women.
Bybee, K. A., & Stevens, T. L. (2013) · PubMed · Cited by 16
Pharmacogenomics of Tamoxifen in a Nutshell--And Who Broke the Nutcracker?
Holmes, F. A., & Liticker, J. D. (2005) · Journal of Oncology Practice · doi:10.1200/jop.2005.1.4.155 · Cited by 14
Radiation Therapy for Breast Cancer
Witteles, R. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.637 · Cited by 12
VENOUS THROMBOSIS AFTER MYOCARDIAL INFARCTION
Kakkar, V. V. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90643-5 · Cited by 11
Tilting the Balance of Dose Modification for Oral Anticancer Drugs?
Bedard, P. L., & Siu, L. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.2372 · Cited by 9
Tuso, P. J. (2014) · The Permanente Journal · doi:10.7812/tpp/13-091 · Cited by 8
Self-citationThe future of surgery in the treatment of breast cancer
Wood, W. C. (2003) · The Breast · doi:10.1016/s0960-9776(03)00154-1 · Cited by 7
Tuso, P. J. (2014) · The Permanente Journal · doi:10.7812/tpp/14-035 · Cited by 6
Self-citationCoagulation and Anticoagulation
Mostafa, G., Cathey, L., & Greene, F. L. (2006) · Springer eBooks · doi:10.1007/978-0-387-44952-4_29 · Cited by 6
Wolberg, A. S., & Mackman, N. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.184580 · Cited by 5
Tamoxifen therapy for patients with breast cancer
Litton, J. K., Buzdar, A. U., Chávez‐MacGregor, M., Gonzalez-Angulo, A. M., & Hortobágyi, G. N. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61236-2 · Cited by 4
Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer
Morrow, P. K. H. (2010) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2010.10.002 · Cited by 3
Perspectives on Surveillance and Survivorship: When to Make the Transition
Shockney, L. D. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0150 · Cited by 2
Research works printed but not linked: 17
- [1]Breast Cancer [Internet] Atlanta, GA: American Cancer Society; p. c2014. [cited 2014 Dec 23]. Available from: www.cancer.org/cancer/breastcancer. [Google Scholar]
- [16]Aalto MT. Adherence of hormonal therapy in breast cancer: an advocate’s perspective. Breast Diseases: A Year Book Quarterly. 2013;24(2):130–2. DOI: http://dx.doi.org/10.1016/j.breastdis.2013.04.005. [Google Scholar] · DOI
- [19]NCCN guidelines for patients: caring for adolescents and young adults [Internet] Fort Washington, PA: National Comprehensive Cancer Network; 2013. [cited 2014 Dec 24]. Available from: www.nccn.org/patients/guidelines/aya/index.html#1/z. [Google Scholar]
- [95]Jordan VC. The development of tamoxifen for breast cancer therapy. In: Jordan VC, editor. Long-term tamoxifen treatment for breast cancer. Madison, WI: University of Wisconsin Press; 1994. pp. 3–26. [Google Scholar]
- [96]Osborne CK, Elledge RM, Fuqua SAW. Estrogen receptors in breast cancer therapy. Science & Medicine. 1996 Feb;3(1):32–41. [Google Scholar]
- [101]Kennecke HF, Ellard S, O’Reilly S, Gelmon KA. New guidelines for treatment of early hormone-positive breast cancer with tamoxifen and aromatase inhibitors. B C Med J. 2006 Apr;48(3):121–6. [Google Scholar]
- [242]National Osteoporosis Foundation . Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2008. [revised 2010 Jan]. [Google Scholar]
- [244]WHO Scientific Group on the Prevention and Management of Osteoporosis . WHO technical report series; 921. Geneva, Switzerland: World Health Organization; 2003. Prevention and management of osteoporosis: report of a WHO scientific group. [Google Scholar]
- [245]Altekruse SF, Kosary CL, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2007 [Internet] Bethesda, MD: National Cancer Institute; 2010. [cited 2015 Jan 16]. Available from: http://seer.cancer.gov/csr/1975_2007/. [Google Scholar]
- [279]Cancer facts and figures 2013 [Internet] Atlanta, GA: American Cancer Society; 2013. [cited 2015 Jan 16]. Available from: www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/2013-cancer-facts-and-figures.pdf. [Google Scholar]
- [286]Howlader N, Noone AM, Krapcho M, editors. SEER cancer statistics review, 1975–2011 [Internet] Bethesda, MD: National Cancer Institute; updated 2014 Dec 17[cited 2015 Jan 20]. Available from: http://seer.cancer.gov/csr/1975_2011/. [Google Scholar]
- [315]Reis LAG, Melbert D, Krapcho M, editors. SEER cancer statistics review, 1975–2005[Internet] Bethesda, MD: National Cancer Institute; 2008. [cited 2015 Jan 20]. Available from: http://seer.cancer.gov/archive/csr/1975_2005/. [Google Scholar]
- [317]Curtis RE, Ron E, Hankey BF, Hoover RN. New malignancies following breast cancer. In: Curtis RE, Freedman DM, Ron E, editors. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. NIH pub 05-5302. Bethesda, MD: National Cancer Institute; 2006. pp. 181–205. [Google Scholar]
- [429]Touchette DR, Shapiro NL. Medication compliance, adherence, and persistence: current status of behaviorial and educational intervention to improve outcomes. J Manag Care Pharm. 2008;14(6 suppl S-d):S2–S10. [Google Scholar]
- [454]What breast cancer survivors can do [Internet] Washington, DC: American Institute for Cancer Research; p. c2014. [cited 2014 Nov 3]. Available from: www.aicr.org/learn-more-about-cancer/infographics/what-breast-cancer-survivors-cando.html. [Google Scholar]
- [469]World Cancer Research Fund International [Internet] London, England: World Cancer Research Fund International; p. c2014. [cited 2015 Feb 3]. Available from: www.wcrf.org/. [Google Scholar]
- [470]Diet, nutrition, physical activity and breast cancer survivors [Internet] London, England: World Cancer Research Fund International; 2014. [cited 2014 Nov 4]. Available from: www.aicr.org/assets/docs/pdf/reports/2014-breast-cancer-survivorship-cup.pdf. [Google Scholar]
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Handbook of Religion and Health
Koenig, H. G., VanderWeele, T., & Peteet, J. R. (2024) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,139
Unmasking senescence: context-dependent effects of SASP in cancer
Faget, D. V., Ren, Q., & Stewart, S. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0156-2 · Cited by 863
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., & Cipolla, C. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 723
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Metadata
- Authors
- Bodai, B. I., & Tuso, P.
- Affiliations
- Director of The Breast Cancer Survivorship Institute in Sacramento, CA..
- Antelope Valley Hospital (US)
- Venue
- The Permanente Journal
- Publisher
- The Permanente Federation
- Published
- 2015-06
- Volume
- 19
- Issue
- 2
- Pages
- 48-79
- ISSN
- 1552-5767 (ISSN-L)
- 1552-5775
- PMC
- PMC4403581
- OpenAlex
- W2153516643
- Cited by
- 397
- References
- 521
- Citations by year
- 2026: 11 · 2025: 35 · 2024: 41 · 2023: 88 · 2022: 35 · 2021: 45 · 2020: 29 · 2019: 43 · 2018: 31 · 2017: 25 · 2016: 12 · 2015: 2
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Permanente Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- breast cancer survivorship, long-term treatment side effects, chronic disease, comorbidities, transition to survivorship, lifestyle advice, survivorship care, late effects of cancer treatment
- MeSH terms
- Breast Neoplasms, Female, Humans, Life Style, Lymphedema, Osteoporosis, Patient Compliance, Quality of Life, Radiation Injuries, Thromboembolism, Neoplasms, Second Primary, Treatment Outcome, Disease-Free Survival, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.